These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8767267)

  • 1. [Effect of orally administered polyene antimycotics on the intestinal colonization with yeasts: possibilities and limitations].
    Blaschke-Hellmessen R; Buchmann H; Schwarze R
    Mycoses; 1996; 39 Suppl 1():33-9. PubMed ID: 8767267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amphotericin B level in feces and serum during oral administration in newborns at risk].
    Blaschke-Hellmessen R; Schwarze R
    Mycoses; 1994; 37 Suppl 1():84-8. PubMed ID: 7854372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
    Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
    J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
    Ellepola AN; Samaranayake LP; Khan ZU
    Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates.
    Egusa H; Ellepola AN; Nikawa H; Hamada T; Samaranayake LP
    J Oral Pathol Med; 2000 May; 29(5):206-13. PubMed ID: 10801037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of fungus carriers as a source of infection].
    Müller J
    Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):162-72. PubMed ID: 8333894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes.
    Hoppe JE; Friess D; Niethammer D
    Mycoses; 1995; 38(1-2):41-9. PubMed ID: 7637681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
    Epstein JB; Truelove EL; Hanson-Huggins K; Mancl LA; Chen A; Press OW; Petersdorf SH; Fritsche TR; Epstein JD
    Support Care Cancer; 2004 Jul; 12(7):517-25. PubMed ID: 15108100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk.
    Schäfer-Korting M; Blechschmidt J; Korting HC
    Mycoses; 1996; 39(9-10):329-39. PubMed ID: 9009654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rational use of antimycotics against yeast infections].
    Hof H; Kretschmar M
    Immun Infekt; 1995 Dec; 23(6):209-15. PubMed ID: 8582736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of pathogenic yeasts among open-heart surgery patients-the value of prophylaxis.
    Evans EG
    J Thorac Cardiovasc Surg; 1975 Sep; 70(3):466-70. PubMed ID: 1100919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
    Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K
    J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of murine systemic aspergillosis with polyene-intralipid admixtures.
    Sionov E; Segal E
    Med Mycol; 2004 Feb; 42(1):73-80. PubMed ID: 14982116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyene antibiotics: relative degrees of in vitro cytotoxicity and potential effects on tubule phospholipid and ceramide content.
    Zager RA
    Am J Kidney Dis; 2000 Aug; 36(2):238-49. PubMed ID: 10922301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nystatin prophylaxis in immunocompromised children.
    Taylor TL
    Ann Pharmacother; 1996 May; 30(5):534-5. PubMed ID: 8740337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present state of antimycotic therapy (author's transl)].
    Meinhof W
    Monatsschr Kinderheilkd (1902); 1979 Apr; 127(4):175-8. PubMed ID: 449874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a polyene antifungal agent, liposomal amphotericin B (L-AMB), in a severely burned patient.
    Sasaki J; Matsumoto K; Fujishima S; Morita K; Hori S
    J Chemother; 2014 Oct; 26(5):312-4. PubMed ID: 24070023
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.